Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Deficiency in B12 can result in symptoms such as trouble concentrating, memory problems, and mood changes
This product has no artificial additives, including sweeteners
event-driven endpoint Obstructive Sleep Apnea Status: Phase 3 Planned Focus: OSA severity reduction (apnea-hypopnea index) with CagriSema-induced weight loss Population: Adults with moderate-severe OSA and obesity Timeline: Expected enrollment 2024-2025 NASH/MAFLD Status: Phase 2 Ongoing Focus: Hepatic steatosis, inflammation, and fibrosis improvement Population: Adults with biopsy-confirmed NASH/MAFLD Timeline: Results expected 2025 Heart Failure with Preserved EF Status: Preclinical Planning Focus: HFpEF outcomes in obese patients following substantial weight loss Rationale: Obesity-HFpEF phenotype may benefit from profound weight reduction Timeline: Early development phase Pediatric Obesity Status: Phase 2 Planning Focus: Safety, tolerability, and efficacy in adolescents (12-18 years) Population: Adolescents with obesity (BMI 95th percentile) Timeline: Expected initiation 2025 Oral Formulation Development Status: Preclinical Focus: Oral bioavailability enhancement for cagrilintide using absorption enhancers Rationale: Oral delivery could improve accessibility and adherence Timeline: Research phase
Animals in the first group were not treated with any drug prior to sacrifice
Basford said the study doesnt definitively clarify whether these improvements are due to the biochemical effects of the medicines or are a result of improved self-esteem
Blood samples were obtained at baseline and during the fasting steady-state period (at 30, 20, 10 and 0 min during the last 30 min of the continuous tracer infusion) to assess plasma glucose and insulin concentrations, and isotopic enrichments of glucose and glycerol
